Cookson Peirce & Co’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-87,178
Closed -$10.3M 201
2022
Q1
$10.3M Buy
87,178
+1,329
+2% +$149K 0.6% 54
2021
Q4
$11.1M Buy
85,849
+26,533
+45% +$3.09M 0.62% 49
2021
Q3
$6.71M Buy
+59,316
New +$6.77M 0.41% 74
2020
Q2
Sell
-4,740
Closed -$298K 139
2020
Q1
$298K Sell
4,740
-13,530
-74% -$976K 0.03% 114
2019
Q4
$1.42M Buy
18,270
+573
+3% +$44.7K 0.13% 81
2019
Q3
$1.3M Sell
17,697
-678
-4% -$47.6K 0.11% 83
2019
Q2
$1.13M Sell
18,375
-402,600
-96% -$24.3M 0.1% 89
2019
Q1
$26.8M Sell
420,975
-4,395
-1% -$251K 2.27% 12
2018
Q4
$21.7M Sell
425,370
-4,530
-1% -$229K 2.1% 18
2018
Q3
$24.9M Sell
429,900
-13,923
-3% -$681K 2% 21
2018
Q2
$21.5M Buy
443,823
+202,353
+84% +$9.44M 1.92% 20
2018
Q1
$11.2M Buy
+241,470
New +$10.5M 1.02% 36

Other funds holding EW

Cookson Peirce & Co's EW Position: Q2 2022 in Review

Cookson Peirce & Co sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 87,178 shares — an estimated $10.3M sold.

Cookson Peirce & Co first reported a position in EW in Q1 2018 and held it in 12 quarters. The position peaked at $26.8M in Q1 2019. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Cookson Peirce & Co reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Cookson Peirce & Co sold 87,178 Edwards Lifesciences shares in Q2 2022, an estimated $10.3M.
  • Cookson Peirce & Co first reported a position in Edwards Lifesciences in Q1 2018 and held it in 12 quarters.
  • Cookson Peirce & Co's Edwards Lifesciences position peaked at $26.8M in Q1 2019.
  • 1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Cookson Peirce & Co's 13F filing for Q2 2022, filed 20 Jul 2022.